Form 4 for CRUS CIRRUS LOGIC, INC.
Accepted 2026-04-10 17:02:58 ET · period of report 2026-04-09 · accession 0001273902-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-10 17:02 | 2026-04-09 | CRUS | THOMAS SCOTT | EVP, GC | M - OptEx | $68.56 | +9,942 | 40.3K | +33% | +$681.6K |
| DT | 2026-04-10 17:02 | 2026-04-09 | CRUS | THOMAS SCOTT | EVP, GC | S - Sale+OE | $160.11 | -9,942 | 30.4K | -25% | -$1.59M |
| DT | 2026-04-10 17:02 | 2026-04-09 | CRUS | THOMAS SCOTT | EVP, GC | M - OptEx | $0.00 | -9,942 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-09 | M | A | 9,942 | $68.56 | 40,335 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14,2025. |
| 2 | Common | Common Stock | 2026-04-09 | S | D | 9,942 | $160.11 | 30,393 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14,2025. (F2) The price reported in Table I - Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.00 to $160.30. The reporting person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to any security holder of Cirrus Logic, Inc. or the staff of the SEC upon request. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-04-09 | M | D | 9,942 | $0.00 | 0 | D | $68.56 · — to 2029-11-06 | 9,942 Common Stock | (F3) Only vested shares can be exercised under this option. 25% of the shares vested on 11/6/20; the remaining shares vested monthly over the following 36 months so that the option was fully vested and exercisable on 11/6/23. |